John McHutchinson

517 total citations
11 papers, 428 citations indexed

About

John McHutchinson is a scholar working on Epidemiology, Hepatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John McHutchinson has authored 11 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John McHutchinson's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). John McHutchinson is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). John McHutchinson collaborates with scholars based in United States, France and Italy. John McHutchinson's co-authors include Michael Houghton, Robert Kokka, Barbara Rehermann, Kyong‐Mi Chang, Francis V. Chisari, Charles M. Rice, Michael P. Epstein, D.J. Devlin, Alicia K. Smith and Eric L. Gustafson and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Virology.

In The Last Decade

John McHutchinson

11 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John McHutchinson United States 8 313 239 103 57 55 11 428
Giancarlo Serra Italy 6 465 1.5× 430 1.8× 24 0.2× 15 0.3× 33 0.6× 17 554
Małgorzata Zalewska Poland 10 127 0.4× 150 0.6× 37 0.4× 43 0.8× 24 0.4× 42 294
Ann Atlas Sweden 11 11 0.0× 81 0.3× 276 2.7× 81 1.4× 10 0.2× 16 483
Megan Dring Ireland 8 123 0.4× 101 0.4× 179 1.7× 3 0.1× 28 0.5× 9 521
R. Ivanova France 7 8 0.0× 42 0.2× 128 1.2× 25 0.4× 9 0.2× 13 303
Jennifer H. Campbell United States 9 8 0.0× 94 0.4× 135 1.3× 30 0.5× 9 0.2× 9 552
Beatriz de Felipe Spain 11 15 0.0× 68 0.3× 137 1.3× 11 0.2× 5 0.1× 27 297
Jake A. Robinson United States 12 6 0.0× 59 0.2× 64 0.6× 18 0.3× 24 0.4× 24 393
Jasmini Alagaratnam United Kingdom 9 15 0.0× 49 0.2× 6 0.1× 15 0.3× 5 0.1× 23 270
R Rescaldani Italy 11 4 0.0× 131 0.5× 102 1.0× 18 0.3× 4 0.1× 24 419

Countries citing papers authored by John McHutchinson

Since Specialization
Citations

This map shows the geographic impact of John McHutchinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McHutchinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McHutchinson more than expected).

Fields of papers citing papers by John McHutchinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John McHutchinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McHutchinson. The network helps show where John McHutchinson may publish in the future.

Co-authorship network of co-authors of John McHutchinson

This figure shows the co-authorship network connecting the top 25 collaborators of John McHutchinson. A scholar is included among the top collaborators of John McHutchinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John McHutchinson. John McHutchinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Younossi, Zobair M., Elzafir Elsheikh, Maria Stepanova, et al.. (2015). Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels. Journal of Viral Hepatitis. 22(12). 977–982. 16 indexed citations
2.
Barrett, Lisa Feldman, Anu Osinusi, Anita Kohli, et al.. (2013). 1 ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPY. Journal of Hepatology. 58. S1–S1. 13 indexed citations
3.
Fung, Scott, Peter Kwan, Milotka Fabri, et al.. (2012). Efficacy and safety of tenofovir DF (DF) in chronic hepatitis B virus infected patients with documented lamivudine resistance (LAM-R). 10 indexed citations
4.
Lopatin, Uri, Grushenka H.I. Wolfgang, Gregory E. Chittick, et al.. (2011). 737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS. Journal of Hepatology. 54. S296–S296. 6 indexed citations
5.
Smith, Alicia K., Jason S. Simon, Eric L. Gustafson, et al.. (2011). Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C. Molecular Psychiatry. 17(8). 781–789. 69 indexed citations
6.
McHutchinson, John, Zachary Goodman, M. Rodríguez‐Torres, et al.. (2008). Double blind, randomized, placebo-controlled, multi-center,phase II dose ranging study to assess the antifibrotic activityof farglitazar in chronic hepatitis C infection.. Hepatology. 2 indexed citations
7.
Dienstag, Jules L., John McHutchinson, & Jules L. Dienstag. (2006). Continuing Medical Education Exam 3: January 2006. Gastroenterology. 130(1). 214–217. 4 indexed citations
8.
Pockros, Paul J., et al.. (2003). The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients. Journal of Viral Hepatitis. 10(1). 55–60. 14 indexed citations
9.
Rehermann, Barbara, Kyong‐Mi Chang, John McHutchinson, et al.. (1996). Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. Journal of Virology. 70(10). 7092–7102. 232 indexed citations
10.
Lee, Stephen, John McHutchinson, Robert K. DiNello, et al.. (1992). Improved Detection of Antibodies to Hepatitis C Virus Using a Second Generation Elisa. Advances in experimental medicine and biology. 312. 183–189. 13 indexed citations
11.
Weiner, Amy J., Cindy Christopherson, J. Eric Hall, et al.. (1991). Sequence variation in hepatitis C viral isolates. Journal of Hepatology. 13. S6–S14. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giancarlo Serra Breakdown of academic impact, for papers by Małgorzata Zalewska Breakdown of academic impact, for papers by Ann Atlas Breakdown of academic impact, for papers by Megan Dring Breakdown of academic impact, for papers by R. Ivanova Breakdown of academic impact, for papers by Jennifer H. Campbell Breakdown of academic impact, for papers by Beatriz de Felipe Breakdown of academic impact, for papers by Jake A. Robinson Breakdown of academic impact, for papers by Jasmini Alagaratnam Breakdown of academic impact, for papers by R Rescaldani
Rankless by CCL
2026